Simparica 120 mg Chewable Tablets for Dogs >40–60 kg

Transmission of B. canis canis cannot be completely excluded since D. reticulatus
ticks have to attach to the host before being killed. As an acaricidal effect against D.
reticulatus may take up to 48 hours, transmission of B. canis canis during the first 48
hours cannot be excluded.
The use of the veterinary medicinal product should be based on the local
epidemiological situation including knowledge of the prevalent tick species as
transmission of B. canis by tick species other than D. reticulatus is possible and
should be part of an integrated control program to prevent the transmission of
Babesia canis.

Special precautions for use in animals
In the absence of available data, treatment of puppies less than 8 weeks of age
and/or dogs less than 1.3 kg bodyweight should be based on a benefit-risk
assessment by the responsible veterinarian.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Wash hands after handling the veterinary medicinal product.
The accidental ingestion of the veterinary medicinal product may potentially result in
adverse effects, such as transient excitatory neurological signs. To prevent children
from accessing the veterinary medicinal product, only one chewable tablet at a time
should be removed from the blister pack and only when required. The blister pack
should then be returned into the carton immediately after use and the carton should
be stored out of the sight and reach of children. In case of accidental ingestion, seek
medical advice immediately and show the package leaflet or the label to the
physician.

Revised: February 2024
AN: 03227/2022
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.